Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Chen, Xue Yuan ^a,e   Wang, Shan Mei ^a   Li, Nan ^a   Hu, Yang ^a   Zhang, Yuan ^a   Xu, Jin Fu ^a   Li, Xia ^a   Ren, Jie ^b   Su, Bo ^a   Yuan, Wei Zhong ^b   Teng, Xin Rong ^b   Zhang, Rong Xuan ^a   Jiang, Dian hua ^c   Mulet, Xavier ^d   Li, Hui Ping ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CSIRO   (Australia)

^e HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; IMMUNOLIPOSOME; SURFACTANT PROTEIN A; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; ENCAPSULATION; KIDNEY PARENCHYMA; LIPOSOMAL DELIVERY; LUNG PARENCHYMA; MALE; NONHUMAN; PNEUMONIA; RAT; SPLEEN; STAPHYLOCOCCUS EPIDERMIDIS; SURVIVAL RATE; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; DISEASE MODELS, ANIMAL; LIPOSOMES; LUNG; LUNG INJURY; MALE; NANOCONJUGATES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RATS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875037295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058275     Document Type: Article

References (40)

1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, et al. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178.
2. Grutters JC, van den Bosch JM, (2006) Corticosteroid treatment in sarcoidosis. Eur Respir J 28: 627-636.
3. Peter JV, John P, Graham PL, Moran JL, George IA, et al. (2008) Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 336: 1006-1009.
4. Bellingan GJ, (2002) The pulmonary physician in critical care • 6: The pathogenesis of ALI/ARDS. Thorax 57: 540-546.
5. Eachempati SR, Hydo LJ, Shou J, Barie PS, (2007) Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients. J Trauma 63: 344-350.
6. Ware LB, Matthay MA, (2000) The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349.
7. Hay J, Shahzeidi S, Laurent G, (1991) Mechanisms of bleomycin-induced lung damage. Arch Toxicol 65: 81-94.
8. Matute-Bello G, Frevert CW, Martin TR, (2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: 379-399.
9. Drescher W, Schlieper G, Floege J, Eitner F, (2011) Steroid-related osteonecrosis-an update. Nephrol Dial Transplant 26: 2728-2731.
10. Yokoe J, Sakuragi S, Yamamoto K, Teragaki T, Ogawara K, et al. (2008) Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats. Int J Pharm 353: 28-34.
11. Betageri GV, Black CD, Szebeni J, Wahl LM, Weinstein JN, (1993) Fc-receptor-mediated targeting of antibody-bearing liposomes containing dideoxycytidine triphosphate to human monocyte/macrophages. J Pharm Pharmacol 45: 48-53.
12. Elbayoumi TA, Torchilin VP, (2010) Current trends in liposome research. Methods Mol Biol 605: 1-27.
13. Gregoriadis G, (2008) Liposome research in drug delivery: The early days. J Drug Target 16: 520-524.
14. Asgeirsdóttir SA, Kamps JA, Bakker HI, Zwiers PJ, Heeringa P, et al. (2007) Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium. Mol Pharmacol 72: 121-131.
15. Bendas G, (2001) Immunoliposomes: a promising approach to targeting cancer therapy. BioDrugs 15: 215-224.
16. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, et al. (2006) Surfactant proteins SP-A and SP-D: structure, function and receptors. Molecular Immunology 43: 1293-1315.
17. Gupta N, Manevich Y, Kazi AS, Tao JQ, Fisher AB, et al. (2006) Identification and characterization of p63 (CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 291: 436-446.
18. Madsen J, Tornoe I, Nielsen O, Koch C, Steinhilber W, et al. (2003) Expression and localization of lung surfactant protein A in human tissues. Am J Respir Cell Mol Biol 29: 591-597.
19. Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G, (2003) Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum 48: 2059-2066.
20. Kwak HW, D'Amico DJ, (1995) Determination of dexamethasone sodium phosphate in the vitreous by high performance liquid chromatography. Korean J Ophthalmol 9: 79-83.
21. Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S, (1995) A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1237: 99-108.
22. Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG, (1979) Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis 120: 893-899.
23. Mikawa K, Nishina K, Takao Y, Obara H, (2003) A nitric oxide syuthase inhibitor,attenuates endotoxin-induced acute lung injury in rabbits. Aaesth Analg 97: 1751-1755.
24. Mamot C, Nguyen JB, Pourdehnad M, Hadaczek P, Saito R, et al. (2004) Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol 68: 1-9.
25. Afergan E, Epstein H, Dahan R, Koroukhov N, Rohekar K, et al. (2008) Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release 132: 84-90.
26. Scherphof GL, Kamps JA, (2001) The role of hepatocytes in the clearance of liposomes from the blood circulation. Prog Lipid Res 40: 149-166.
27. Sadzuka Y, Nakade A, Hirama R, Miyagishima A, Nozawa Y, et al. (2002) Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int J Pharm 238: 171-180.
28. Pan H, Niu GQ, Pan J, Lu WY, (2006) Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody. Acta Pharmaceutica Sinica 41: 506-512.
29. Hao H, Wendt CH, Sandhu G, Ingbar DH, (2003) Dexamethasone stimuates transcription of the Na+-K+-ATPaseβ1 gene in adult rat lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 285: 593-601.
30. Devos S, De Bosscher K, Staels B, Bauer E, Roels F, et al. (2003) Inhibition of cytokine production by the herbicide atrazine. Search for nuclear receptor targets. Biochem Pharmacol 65: 303-308.
31. Fernandes AB, Zin WA, Rocco PR, (2005) Corticosteroids in acute respiratory distress syndrome. Braz J Med Biol Res 38: 147-159.
32. Dik WA, McAnulty RJ, Versnel MA, Naber BA, Zimmermann LJ, et al. (2003) Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats. Thorax 58: 765-771.
33. Berlin M, (2010) Recent advances in the development of novel glucocorticoid receptor modulators. Expert Opin Ther Pat 20: 855-873.
34. De Bosscher K, (2010) Selective Glucocorticoid Receptor modulators. J Steroid Biochem Mol Biol 120: 96-104.
35. Wang XQ, Zhou X, Zhou Y, Rong L, Gao L, et al. (2008) Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors. Respirology 13: 772-780.
36. Bertorelli G, Pesci A, Peveri S, Mergoni M, Corradi A, et al. (2008) Alpha glucocorticoid receptor expression in different experimental rat models of acute lung injury. Pulm Pharmacol Ther 21: 214-221.
37. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, et al. (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317: 1565-1570.
38. Thompson BT, (2010) Corticosteroids for ARDS. Minerva Anestesiol. 76: 441-447.
39. Bonniaud P, Margetts PJ, Ask K, Flanders K, Gauldie J, et al. (2005) TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol 175: 5390-5395.
40. Coward WR, Saini G, Jenkins G, (2010) The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 4: 367-388.